Tag: PAETC

Cross-posted from HIV.gov

On the closing day of the 2022 US Conference on HIV/AIDS (USCHA) in Puerto Rico, the final plenary session focused on the response to the current monkeypox outbreak. On behalf of HIV.gov, Timothy P. Harrison, Ph.D., Principal Deputy Director for the Office of Infectious Disease and HIV/AIDS Policy, spoke with Dr. Demetre C. Daskalakis, White House National Monkeypox Response Deputy Coordinator, about the same topic.

The final session of the conference was a plenary focused on the national response to monkeypox, which is having a disproportionate impact on people with and experiencing risk for HIV. The session featured presenters from CDC, HRSA’s Ryan White HIV/AIDS Program, and representatives from a health department and community-based organizations in New York, Los Angeles, and Boston discussing their agencies’ approaches to addressing the monkeypox outbreak. Dr. Demetre Daskalakis underscored that a syndemic approach to the response to monkeypox is essential given both the common risk factors and populations affected by HIV, STIs, and monkeypox. He applauded and encouraged the important roles the HIV community has played and will continue to play in the monkeypox response. He highlighted opportunities to connect those getting the monkeypox vaccine or treatment with HIV testing and PrEP or HIV treatment, vital actions to end both the monkeypox outbreak and HIV epidemic equitably across all populations. (Follow HIV.gov’s Monkeypox page for more information and resources.)

Also featured in the closing session was a presentation of several panels of the National AIDS Memorial quilt and an invitation to participate in the new Change the Pattern initiative highlighting Black and Latino lives lost to HIV.

USCHA is the largest HIV-related gathering in the United States, bringing together thousands of participants from all segments of the HIV community. Organized by NMAC, the 2022 conference was held in San Juan, Puerto Rico, from October 8-11 with over 3,000 participants registered. The conference featured over 120 institutes, workshops, and posters addressing issues in biomedical HIV prevention, aging, service delivery, and telehealth, prioritizing the issues of people with HIV and the next steps in ending the epidemic.

Cross-posted from HIV.gov

The 2022 US Conference on HIV/AIDS (USCHA) opened in San Juan, Puerto Rico, on Saturday, October 8. The opening plenary session put the spotlight on the HIV response in Puerto Rico, and HIV.gov spoke with Lieutenant Alberto Pina, the PACE Deputy Director in Los Angeles, about his reflections on USCHA.

Lieutenant Pina was moved by the energy and excitement of the session, and he also discussed the significance of hosting the conference in San Juan.

The opening plenary highlighted HIV in Puerto Rico and Latinx communities. Presenters included doctors who have been in the HIV field since the earliest days of the epidemic and who have treated people with HIV on the island; a lawyer fighting against stigma and discrimination; and a clinician who worked to eliminate mother-to-child transmission of HIV in Puerto Rico in 1994, many years before other countries did the same. Several people with HIV passionately shared their personal experiences of living with the virus and working to educate others in their communities about HIV prevention and treatment services, including PrEP. Presenters also discussed the current state of HIV, including successes and challenges of working toward ending the HIV epidemic in Puerto Rico, which  is one of the 57 priority areas for the Ending the HIV Epidemic in the U.S. initiative.

The USCHA is the largest HIV-related gathering in the United States, bringing together thousands of participants from all segments of the HIV community. Organized by NMAC, the 2022 conference is being held in San Juan, Puerto Rico, from October 8-11 with more than 3,000 participants registered. The conference features over 120 institutes, workshops, and posters addressing issues in biomedical HIV prevention, aging, service delivery, and telehealth, prioritizing the issues of people with HIV and the next steps in ending the epidemic.

Follow HIV.gov on Facebook, Twitter, and Instagram for more conference updates.

October 15 is National Latinx AIDS Awareness Day (NLAAD), which was first observed in 2003 by the Hispanic Federation and the Latino Commission on AIDS. NLAAD is an opportunity to help address the disproportionate impact of HIV on Hispanic/Latinx communities, promote HIV testing, and stop HIV stigma.

Let’s take a deeper look at HIV among Hispanic/Latinx People:

HIV has a disproportionate impact on the Hispanic/Latinx population. In 2020, Hispanic/Latinx people represented 27% of new HIV diagnoses, despite making up only 19% of the U.S. population. The Hispanic/Latinx community faces unique cultural and societal challenges in HIV prevention, treatment, and care, including language barriers and mistrust of the health care system.

In 2021, 23% of new HIV diagnoses among Hispanic/Latinx people were diagnosed late, meaning those individuals were diagnosed with stage 3 HIV (AIDS) within 3 months of their initial HIV diagnosis. In the same year, only an estimated 45% of Hispanic/Latinx individuals reported ever being tested for HIV.

Cross-posted from AIDSVu

Access more Infographics and Data from AIDSVu

NLAAD Campaign: You Choose!

NLAAD’s campaign brings together Hispanic/Latinx communities and service providers, and organizations providing services to Hispanic/Latinx throughout the U.S. and territories under one theme. This year’s theme is “You Choose!” to create awareness about choosing HIV medication options better suited to each individual.

Learn more from NLAAD

NLAAD Upcoming In-Person Events

NLAAD Infographics

Resources

Dr. Sonya Arreola on Health Inequities Among Hispanic/Latinx Populations

Dr. Sonya Arreola, PhD, MPH is the director of Arreola Research and serves as a consulting faculty/mentor in the Visiting Professors Program for University of California San Francisco’s Department of Medicine and Prevention Science.

Access the Q&A Now

Webinars

HIV Vaccine Research Updates and Latinx Engagement

The presentation focuses on HIV vaccine, how they are designed, how vaccine research trials are conducted and the importance of engaging Latinx.

Presenter:
Jorge Benitez, Community Engagement Coordinator, Columbia Research Unit

Facilitated Live on: October 14, 2022

Access Now

Social Determinants of Health and HIV in Latinx and Communities of Color

This webinar will address the intersection of the social determinants of health and their impact on HIV among the Latinx community as well as on communities of color in general – and the disparate impact on health equity and long-term health outcomes among medically underserved populations

Presenter:
Gregorio Millett, MPH,
amfAR – The foundation For AIDS Research

Facilitated Live on: October 6, 2020

Access Now

Watch more webinars from NLAAD

Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection—Medical Monitoring Project, United States 2020 Cycle (June 2020–May 2021)

This new report finds that services like dental care, housing, and SNAP/WIC can help people with HIV access and stay in routine HIV care and be virally suppressed, but those needs are not always met.

Learn more in the report

About the HIV Clinical Leadership Program

The HIV Clinical Leadership Program is an established, postdoctoral fellowship aimed at developing HIV specialists who are knowledgeable and committed to addressing the health inequities our patients face at an individual and systemic level. The HIV Clinical Leadership Program have a proven track record of placing fellows in competitive leadership career positions throughout the United States.

   

Candidates will be competitively selected through a national search for this two-year clinical fellowship program. Those selected will participate in the HIV Clinical Leadership Program with full fellowship salary and benefits.

Up to 4 fellows may be selected for each cohort.

Fellows with eligible academic loans may receive up to $150,000 in loan repayment if they continue to provide HIV-related services in undeserved communities.

Learn more and apply now!

Desired qualifications for potential candidates include:

• A strong interest in primary care and HIV medicine
• A strong interest in pursuing and implementing outpatient quality improvement or system innovation
• A sincere commitment to work with underserved communities

Due to the current trends of the HIV epidemic in the United States, physicians from the South and Mid-Atlantic states strongly encouraged to apply! 

Black, Latinx, Indigenous, BIPOC, LGBTQIA2S+ physicians strongly encouraged to apply!